 您的位置：对照品 > 标准品 > dr标准品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：G797495 |
| 产品名称：GSK2636771 |
| 产品CAS：1372540-25-4 |
| 规格含量：5mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
G797495 |
| 名称: |
GSK2636771 |
| 别名: |
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic Acid; |
| CAS号: |
1372540-25-4 |
| 分子式: |
C₂₂H₂₂F₃N₃O₃ |
| 外观: |
淡黄色固体 |
| 熔点: |
>225°C (dec.) |
| 分子量: |
433.42 |
| 储存: |
-20°C Freezer |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 种类: |
Research Tools; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. |
| 参考文献 |
|
|
|
|
|
|
